Guangdong Jiangxi Wannianqing Cement announced that the company is participating in the national centralized procurement alliance for Chinese Patent Medicine, and the product Ginseng and Astragalus Sugar-lowering Tablets are expected to be selected. In 2023, the sales revenue of Ginseng and Astragalus Sugar-lowering Tablets was 0.113 billion yuan, accounting for 38.74% of the company's total revenue. The selected price is 33.02 yuan/bottle, and the procurement cycle will be from the execution date until December 31, 2027. If selection is confirmed and a procurement contract is signed, it will be beneficial to expand sales scale, increase market share, and enhance brand influence.